Kristien Boelaert

161 - 170 out of 170Page size: 10

Publications

  1. Published

    Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine

    Kristien Boelaert, Barbara Torlinska & Jayne Franklyn, May 2013, In: The Journal of clinical endocrinology and metabolism. 98, 5, p. 1869-82 14 p.

    Research output: Contribution to journal › Article › peer-review

  2. Published

    PTTG and FGF-2 -novel potential molecular indicators for thyroid cancer

    Kristien Boelaert, Christopher McCabe, Lesley Tannahill, Neil Gittoes, Michael Sheppard & Jayne Franklyn, 1 Jan 2002, p. OR 61-62.

    Research output: Contribution to conference (unpublished) › Paper

  3. Published

    The SH3 domain of PTTG differentially mediates FGF-2 transactivation and cell transformation

    Kristien Boelaert, Lesley Tannahill, Jasbir Moore, Lawrence Young, Michael Sheppard, Neil Gittoes, Jayne Franklyn & Christopher McCabe, 1 Jan 2002, p. OR 40-42.

    Research output: Contribution to conference (unpublished) › Paper

  4. Published

    Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers?

    Kristien Boelaert & Jayne Franklyn, 8 Mar 2003, In: Lancet. 361, 9360, p. 796-797 2 p.

    Research output: Contribution to journal › Review article

  5. Published

    A potential role for human securin/PTTG in the developing human fetal brain

    Kristien Boelaert, Christopher McCabe, Lesley Tannahill, Shiaoyng Chan, Neil Gittoes, Mark Kilby & Jayne Franklyn, 1 Jan 2003, p. 164. 1 p.

    Research output: Contribution to conference (unpublished) › Abstract

  6. Published

    Using an increased fixed dose of 1311 (600MBq) leads to improved outcome in patients with hyperthyroidism

    Kristien Boelaert, Michael Sheppard, Stephen Gough & Jayne Franklyn, 1 Jan 2007, p. P312.

    Research output: Contribution to conference (unpublished) › Abstract

  7. Published

    Older Subjects with Hyperthyroidism Present with a Paucity of Symptoms and Signs: A Large Cross-Sectional Study

    Kristien Boelaert, Barbara Torlinska, Roger Holder & Jayne Franklyn, 14 Apr 2010, In: Journal of Clinical Endocrinology and Metabolism. 95, 6, p. 2715-2726 12 p.

    Research output: Contribution to journal › Article

  8. Published

    Expression of 11beta hydroxysteroid dehydrogenase isozyme mRNAs in normal pituitary and pituitary adenomas

    John Ayuk, Kristien Boelaert, Michael Sheppard, Martin Hewison, Paul Stewart & Neil Gittoes, 1 Jan 2001, p. OC17.

    Research output: Contribution to conference (unpublished) › Paper

  9. Published

    Switch in expression of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) mRNAs in pituitary adenomas

    John Ayuk, Kristien Boelaert, Michael Sheppard, Martin Hewison, Paul Stewart & Neil Gittoes, 1 Jan 2001, p. OR34-1.

    Research output: Contribution to conference (unpublished) › Paper

  10. Published

    Biochemical analysis of radioiodine uptake enhancement in endocrine cancer

    Alice Fletcher, Hannah Nieto, Martin Read, Kristien Boelaert, Christopher McCabe & Vicki Smith, 1 Nov 2018, In: Endocrine Abstracts. 59, 1 p., OC2.4.

    Research output: Contribution to journal › Article › peer-review

Previous 1...13 14 15 16 17 Next